Ignite Creation Date:
2025-12-25 @ 12:26 AM
Ignite Modification Date:
2026-02-23 @ 9:21 PM
Study NCT ID:
NCT03374358
Status:
COMPLETED
Last Update Posted:
2021-09-05
First Post:
2017-12-02
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Effect on Liver Fat and Metabolic Parameters When Switching a Protease Inhibitor or Efavirenz to Raltegravir
Sponsor:
Helsinki University Central Hospital
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
OBERAL
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | INDUSTRY | View |